236 related articles for article (PubMed ID: 15275748)
1. Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies.
Aubel B; Kayser V; Mauborgne A; Farré A; Hamon M; Bourgoin S
Pain; 2004 Jul; 110(1-2):22-32. PubMed ID: 15275748
[TBL] [Abstract][Full Text] [Related]
2. Evidence for adenosine- and serotonin-mediated antihyperalgesic effects of cizolirtine in rats suffering from diabetic neuropathy.
Aubel B; Kayser V; Farré A; Hamon M; Bourgoin S
Neuropharmacology; 2007 Feb; 52(2):487-96. PubMed ID: 17027046
[TBL] [Abstract][Full Text] [Related]
3. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
Kajiyama S; Kawamoto M; Shiraishi S; Gaus S; Matsunaga A; Suyama H; Yuge O
Brain Res; 2005 May; 1044(1):76-86. PubMed ID: 15862792
[TBL] [Abstract][Full Text] [Related]
4. Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat.
Lee SE; Kim JH
Neurosci Res; 2007 Jul; 58(3):245-9. PubMed ID: 17428562
[TBL] [Abstract][Full Text] [Related]
5. Increased tumor necrosis factor-alpha and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs.
Bianchi M; Martucci C; Ferrario P; Franchi S; Sacerdote P
Anesth Analg; 2007 Apr; 104(4):949-54. PubMed ID: 17377112
[TBL] [Abstract][Full Text] [Related]
6. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
7. The novel analgesic, cizolirtine, inhibits the spinal release of substance P and CGRP in rats.
Ballet S; Aubel B; Mauborgne A; Poliénor H; Farré A; Cesselin F; Hamon M; Bourgoin AS
Neuropharmacology; 2001 Mar; 40(4):578-89. PubMed ID: 11249967
[TBL] [Abstract][Full Text] [Related]
8. Effect of selol on the opioids activity in streptozotocin induced hyperalgesia.
Bujalska M; Winecka R; Gumułka SW
Acta Pol Pharm; 2008; 65(6):691-6. PubMed ID: 19172850
[TBL] [Abstract][Full Text] [Related]
9. Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms.
Daulhac L; Mallet C; Courteix C; Etienne M; Duroux E; Privat AM; Eschalier A; Fialip J
Mol Pharmacol; 2006 Oct; 70(4):1246-54. PubMed ID: 16868181
[TBL] [Abstract][Full Text] [Related]
10. The effect of low-dose insulin on mechanical sensitivity and allodynia in type I diabetes neuropathy.
Hoybergs YM; Meert TF
Neurosci Lett; 2007 May; 417(2):149-54. PubMed ID: 17412508
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection.
Bach-Rojecky L; Salković-Petrisić M; Lacković Z
Eur J Pharmacol; 2010 May; 633(1-3):10-4. PubMed ID: 20123097
[TBL] [Abstract][Full Text] [Related]
12. Gabapentin augments the antihyperalgesic effects of diclofenac sodium through spinal action in a rat postoperative pain model.
Narai Y; Imamachi N; Saito Y
Anesth Analg; 2012 Jul; 115(1):189-93. PubMed ID: 22467888
[TBL] [Abstract][Full Text] [Related]
13. Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats.
Hasanein P; Soltani N
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1127-31. PubMed ID: 19413593
[TBL] [Abstract][Full Text] [Related]
14. The effects of galanin on neuropathic pain in streptozotocin-induced diabetic rats.
Xu X; Liu Z; Liu H; Yang X; Li Z
Eur J Pharmacol; 2012 Apr; 680(1-3):28-33. PubMed ID: 22306246
[TBL] [Abstract][Full Text] [Related]
15. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
[TBL] [Abstract][Full Text] [Related]
16. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain.
Kuhad A; Sharma S; Chopra K
Eur J Pain; 2008 Jul; 12(5):624-32. PubMed ID: 18055235
[TBL] [Abstract][Full Text] [Related]
17. Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats.
Anjaneyulu M; Chopra K
Indian J Exp Biol; 2004 Aug; 42(8):766-9. PubMed ID: 15573524
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice.
Rashid MH; Inoue M; Bakoshi S; Ueda H
J Pharmacol Exp Ther; 2003 Aug; 306(2):709-17. PubMed ID: 12724350
[TBL] [Abstract][Full Text] [Related]
19. Antihyperalgesic and antiallodynic effect of sirolimus in neuropathic pain and the role of cytokines in this effect.
Orhan CE; Onal A; Ulker S
Neurosci Lett; 2010 Aug; 481(1):17-20. PubMed ID: 20600616
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats.
Yamamoto H; Shimoshige Y; Yamaji T; Murai N; Aoki T; Matsuoka N
Neuropharmacology; 2009 Sep; 57(4):403-8. PubMed ID: 19591853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
